Attached files
| file | filename |
|---|---|
| EX-31.3 - EXHIBIT 31.3 - Rasna Therapeutics Inc. | exhibit313.htm |
| EX-10.3 - EXHIBIT 10.3 - Rasna Therapeutics Inc. | exhibit103.htm |
| 10-K/A - 10-K/A - Rasna Therapeutics Inc. | a0331201710-ka.htm |
Exhibit 31.4
CERTIFICATION BY CHIEF ACCOUNTING OFFICER PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Tiziano Lazzaretti, certify that:
1. | I have reviewed this Amendment No. 1 to Form 10-K/A of Rasna Therapeutics, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
Dated: June 30, 2017
/s/ Tiziano Lazzaretti | |
Name: Tiziano Lazzaretti Title: Chief Financial Officer (Principal Financial Officer) | |